She took the time to really listen to what was going on and how it was making me feel.Terri LydaThis is the very best place to go for hormone treatments
Key protective strategies include: Pre-treatment ophthalmologic evaluation : Establish baseline retinal status before initiating GLP-1 therapy, particularly in patients with diabetes duration exceeding 10 years or poor prior glycemic control Individualized medication titration : Consider a more gradual dose escalation approach to avoid precipitous drops in blood glucose for patients with advanced diabetic retinopathy, in coordination with ophthalmology care Appropriate monitoring : Discuss with your healthcare provider whether more frequent eye examinations are needed based on your individual risk factors and baseline retinal status Prompt reporting of visual symptoms : Contact your healthcare provider immediately if you experience sudden vision loss, new or dense floaters, flashing lights, a "curtain" over your vision, eye pain with vision changes, or any sudden vision disturbance Patients without pre-existing diabetic retinopathy can generally follow standard eye examination schedules and do not require additional ophthalmologic monitoring solely due to GLP-1 use
Cardiovascular benefits have been demonstrated with several GLP-1 receptor agonists, including reduced risk of major adverse cardiovascular events in patients with established cardiovascular disease
Blood and urine tests can show how the kidneys are working and if there are signs of infection or ketone buildup
Importantly, GLP-1 receptor agonists are not cosmetic treatments
